David Miller, Author at iPharmg

LENZ Therapeutics Announces FDA Acceptance of New Drug...

2 years ago

SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ or...

2 years ago

FORT LEE, NEW JERSEY, Oct. 21, 2024 – Elevar Therapeutics, Inc., a majority-owned subsidiary of...

2 years ago

Lund, Sweden — 22 October 2024 — Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food...

2 years ago

4790789600$0.00 Otsuka America Pharmaceutical, Inc. has launched a new customer engagement approach...

2 years ago

Melbourne (Australia) | 24 October 2024 — Telix today announces that the United States (U.S.)...

2 years ago

CLEVELAND, Oct. 29, 2024 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today...

2 years ago

Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under...

2 years ago

At AAPS PharmSci 360, Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development...

2 years ago

2 years ago

As many as 30% of people living with severe hemophilia A develop inhibitors such as TFPI, which can...